Accelerated corneal crosslinking (A-CXL) is hampered by rapid stromal oxygen depletion at higher UVA intensities. This study developed biocompatible graphitic carbon nitride (g-C3N4) quantum dots (QDs) and riboflavin/g-C3N4 QDs composites (RF@g-C3N4 QDs) as oxygen self-sufficient platforms for A-CXL. Both showed excellent photocatalytic oxygen generation, high ROS yield, and biosafety. A-CXL using g-C3N4 QDs or RF@g-C3N4 QDs was superior to the standard RF A-CXL protocol, indicating enhanced corneal strengthening. This suggests potential application of g-C3N4 QDs in A-CXL for corneal ectasias.
Publisher
Nature Communications
Published On
Jun 29, 2024
Authors
Mei Yang, Tingting Chen, Xin Chen, Hongxian Pan, Guoli Zhao, Zhongxing Chen, Nan Zhao, Qianfang Ye, Ming Chen, Shenrong Zhang, Rongrong Gao, Keith M. Meek, Sally Hayes, Xiaowei Ma, Xin Li, Yue Wu, Yiming Zhang, Na Kong, Wei Tao, Xingtao Zhou, Jinhai Huang
Tags
Accelerated corneal crosslinking
Graphitic carbon nitride
Oxygen generation
Photocatalytic
Corneal strengthening
Biosafety
Quantum dots
Related Publications
Explore these studies to deepen your understanding of the subject.